Aurinia Pharmaceuticals Inc. (AUPH)

NASDAQ: AUPH · Real-Time Price · USD

16.29

-0.19 (-1.15%)

At close: Aug 28, 2026, 4:00 PM EDT

16.35

+0.06 (0.37%)

After-hours: Aug 28, 2026, 7:30 PM EDT

Aurinia Pharmaceuticals Financials Overview

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Revenue & Profits

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Revenue	311.51	283.06	235.13	175.51	134.03	45.61
Revenue Growth	19.76%	20.38%	33.97%	30.95%	193.89%	-9.01%
Gross Profit	242.61	217.89	186.1	111.72	83.38	-6.63
Operating Income	160.45	116.26	12.52	-85.79	-111.47	-180.74
Net Income	314.11	287.2	5.75	-78.02	-108.18	-180.97
Earnings Per Share	2.30	2.07	0.04	-0.54	-0.76	-1.40
EPS Growth	447.94%	5075.00%	-	-	-	-

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
United States	263.84	210.1	157.96	102.46	45.49
Japan	19.21	25.04	17.56	31.48	-
Total	283.06	235.13	175.51	134.03	45.61

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Cash & Investments	443.02	397.94	358.44	350.37	389.31	465.82
Total Debt	64.14	74.81	79.37	97.61	8.09	8.74
Net Cash (Debt)	378.89	323.13	279.07	252.76	381.22	457.08
Net Cash Growth	62.46%	15.79%	10.41%	-33.70%	-16.60%	17.22%
Net Cash Per Share	2.78	2.33	1.91	1.76	2.69	3.53

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Operating Cash Flow	175.24	135.66	44.39	-33.46	-79.53	-157.69
Capital Expenditures	-0.18	-0.25	-0.28	-0.72	-0.29	-0.3
Free Cash Flow	175.07	135.41	44.11	-34.18	-79.82	-158
Free Cash Flow Growth	89.41%	206.99%	-	-	-	-

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Gross Margin	77.88%	76.98%	79.15%	63.66%	62.21%	-14.53%
Operating Margin	51.51%	41.07%	5.32%	-48.88%	-83.17%	-396.31%
Pretax Margin	51.48%	40.33%	3.17%	-44.14%	-79.35%	-395.15%
Profit Margin	100.84%	101.47%	2.45%	-44.45%	-80.71%	-396.81%
FCF Margin	56.20%	47.84%	18.76%	-19.47%	-59.55%	-346.44%

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Aug '26 Aug 31, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
PE Ratio	7.07	7.32	223.53	-	-	-
Forward PE	20.88	19.69	24.06	-	-	-
P/FCF Ratio	12.38	15.53	29.15	-	-	-
PS Ratio	6.96	7.43	5.47	7.36	4.58	65.03